Abbott Stock To Go Ex-dividend Tomorrow (ABT)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- The ex-dividend date for Abbott Laboratories (NYSE: ABT) is tomorrow, January 11, 2013. Owners of shares as of market close today will be eligible for a dividend of 14 cents per share. At a price of $33.71 as of 9:30 a.m. ET, the dividend yield is 1.7%.

The average volume for Abbott has been 17 million shares per day over the past 30 days. Abbott has a market cap of $52.72 billion and is part of the health care sector and drugs industry. Shares are down 49.1% year to date as of the close of trading on Wednesday.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company has a P/E ratio of 8.2, below the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Abbott as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, notable return on equity, reasonable valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. You can view the full Abbott Ratings Report.

See our dividend calendar or top-yielding stocks list.

Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade.
null

If you liked this article you might like

Fight Off Complacency: Cramer's 'Mad Money' Recap (Fri 9/15/17)

Alibaba, Qorvo, Abbott Laboratories, Square: 'Mad Money' Lightning Round

Walmart Is One of 63 Companies Contributing Massively to Aid Harvey Relief

Abbott Updates Pacemaker, Defibrillator Software to Protect Against Hacking